Ferrer Allocates, on Average, More Than 40% of its Profits to Social and Environmental Projects for the Third Consecutive Year
The pharmaceutical company Ferrer, certified as a B Corp in 2022, has again shown that there is another way of doing business, with an ethical business approach that contributes to a better society. Over the past three years, Ferrer has allocated over 40% on average of its net profits to various social and environmental projects aimed at creating a fairer and more equitable society. As stated in the company’s Sustainability Report, in 2022, 47% of profits were reinvested, carrying out the company's commitment to making a positive impact in society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230728150654/en/
Ferrer's 2022 Sustainability Report front page (Photo: Ferrer)
"As a company, we have an obligation and responsibility to put business profitability and social benefit on an equal footing. We believe that the pharmaceutical business is not an end in itself, but a means to generate substantial social change. We are aware that we still have a long way to go, but we want to encourage other companies to follow the same path," says Mario Rovirosa, Ferrer’s CEO.
To inspire other companies and extend the positive impact beyond Ferrer itself, various initiatives have been launched involving business partners, suppliers and other companies. The Suppliers for Good program is an example in which Ferrer aims to support and guide its suppliers in improving their Environmental, Social and Governance (ESG) practices. An ESG evaluation process for suppliers was launched, and by 2022, 320 suppliers had already been evaluated through the Ecovadis platform, including nearly 50% of suppliers identified as significant. As a result, in 2022 the company was recognized as a leader in Carbon Disclosure Project Supplier Engagement. As a further consequence of this initiative, Ferrer has been certified EcoVadis Gold.
A similar project has also been launched to involve business partners, called Partners for Good. The project consists of evaluating and promoting environmental, social and corporate governance performance among selected partners and defining actions to support and involve them in making a positive impact in society.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230728150654/en/
Contact information
Ferrer
asendin@ferrer.com
Tel.: +34 936 003 779
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Clarity AI Honored in Fast Company Magazine’s 2023 “Brands That Matter” List4.10.2023 10:24:00 EEST | Press release
Clarity AI, the leading sustainability technology platform, has been named to Fast Company’s prestigious annual list of “Brands That Matter” in 2023. With this list, Fast Company, the world's leading business media brand, aims to get beyond “corporate vision statements and management talking points” and recognize brands that “clearly generate enthusiasm among their customers, offering a model of what other brands should be aiming for, and what a brand, at its best, can achieve.” Clarity AI was selected among more than 1,000 entries for its contribution to allowing “companies, investors, and more to ensure they’re investing sustainably by tracking metrics ranging from data on the climate impact to gender equality and diversity on the executive boards of prominent companies.” Additionally, Fast Company highlights Clarity AI’s role in “improving artificial technologies and understanding the multitude of benefits they can offer.” Rebeca Minguela, Founder & CEO of Clarity AI, said: “We're h
Uusi kysely: 66% suomalaisista työntekijöistä haluaisi kotona työskentelystä lain suojaaman oikeuden4.10.2023 10:00:00 EEST | Tiedote
Yhteistyötä tukevia ratkaisuja tarjoavan tekniikkayrityksen Owl Labsin hiljattain toteuttama kysely selvittää pohjoismaisten työntekijöiden asennoitumista etätyöhön. The State of Hybrid Work Report 2023 -tutkimukseen osallistui 2 000 vastaajaa Suomesta, Ruotsista, Norjasta ja Tanskasta. Raportista selviää, että peräti 66% suomalaisista työntekijöistä haluaisi etätyöstä tehtävän lain suojaaman oikeuden. Tämä kertoo joustavien työolojen kasvavasta suosiosta. Tutkimuksen mukaan 63% kaikista pohjoismaisista työntekijöistä on samaa mieltä oikeudesta etätyöhön. Tuki etätyölle laillisena oikeutena jakautuu eri Pohjoismaissa seuraavasti: 65% ruotsalaisista, 63% norjalaisista ja 57% tanskalaisista työntekijöistä tukee ajatusta. Owl Labsin toimitusjohtaja Frank Weishaupt sanoo: “Pohjoismaisten työntekijöiden yksimielisyys kotona työskentelystä lain suojaamana oikeutena kertoo muutoksista työntekijöiden asenteissa työympäristöään kohtaan. Se vahvistaa, miten tärkeänä työn ja vapaa-ajan välistä ta
ABN AMRO and Motive Partners form strategic partnership4.10.2023 09:30:00 EEST | Press release
The move demonstrates a joint commitment from two sizable financial technology investors to support continued innovation and growth in the evolving fintech landscape. Motive Ventures, the early-stage venture arm of Motive Partners, will manage the ABN AMRO Ventures Fund (AAV), consisting of 15 early-stage companies. In addition, ABN AMRO will become a significant investor in Motive-managed vehicles. With funding in the financial services industry declining by 70% between 2021 and 2022, and numerous venture capitalists reducing their investment programmes, Motive Partners and ABN AMRO are charting a new course. Their partnership unites two leading venture platforms, each with decades of fintech expertise and a dedication to innovation in both financial services and venture capital. Their goal is to strengthen the fintech sector and boost innovation by bringing Motive Partners’ ecosystem and experts to the AAV portfolio and ABN AMRO’s broader network. Motive Ventures’ portfolio consists
Desktop Health Announces that Flexcera™ Smile Ultra+ is now Available in Europe, Following Recent Class IIa MDR Certification by the European Union4.10.2023 09:00:00 EEST | Press release
Desktop Health™, the trusted health care brand of Desktop Metal (NYSE:DM), announced that its popular Flexcera™ Smile Ultra+ dental resin, for 3D printing permanent and temporary restorations, is now available for purchase in Europe following its successful certification as a Class IIa medical device under the European Union Medical Device Regulation (MDR). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231004075864/en/ Desktop Health's Flexcera™ Smile Ultra+ dental resin for 3D printing permanent and temporary restorations is now available for purchase in Europe following its successful certification as a Class IIa medical device under the European Union Medical Device Regulation (MDR). (Photo: Business Wire) Flexcera Smile Ultra+ delivers exceptional strength, life-like aesthetics, and the long-term performance expected from a permanent restoration material. Already an FDA 510(k) Class II cleared material, Flexcera Smile U
Velsera to Showcase Seven Bridges Bioinformatics Platform at BioTechX Europe4.10.2023 08:03:00 EEST | Press release
Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, is proud to announce its title sponsorship at BioTechX Europe in Basel, Switzerland, where it will showcase its industry-leading Seven Bridges bioinformatics platform. This conference is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. One of the keynote presentations, sponsored by Velsera, will be on the topic of “Digital Transformation of Early Research at Novo Nordisk and Leveraging AI/ML for Drug Discovery", featuring Asli Ismihan Ozen, head of research engineering, digital science and innovation at Novo Nordisk. She takes the stage at 9:20 am on Wednesday, Oct. 4. Additionally, Jack DiGiovanna, Velsera’s senior vice president of science strategy, will present on “Unleashing the Power of Neoantigens”, with an insightful look at solving complex problems through intero
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom